Perinatal Outcome After Premature Rupture of Membranes
NCT01538030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2012-08-15
Summary
Premature rupture of membranes is an important cause of neonatal morbidity and mortality, mainly because of the complications associated with this pathology (oligohydramnios, cord compression or prolapse, infection). When rupture of the membranes occur the risk of cord compression increases but there is little evidence regarding this complication and amniotic fluid volume. The investigator's focus are the perinatal outcomes according to amniotic fluid volume (\< 5 or \>5).
Conditions
- Fetal Membranes
- Premature Rupture
Sponsors & Collaborators
-
Saint Thomas Hospital, Panama
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2012-08-31
- Completion
- 2012-08-31
Countries
- Panama
Study Locations
More Related Trials
-
PPROM Registry (Preterm Premature Rupture of Membranes)
NCT02997345 ·Status: RECRUITING
-
Monitoring of the Inflammatory Response of Patients With Premature Rupture of Membranes With Bedside Tests
NCT00940043 ·Status: COMPLETED
-
Digital vs. Speculum Exams for PPROM
NCT05773014 ·Status: RECRUITING ·Phase: NA
-
Repeat Antenatal Corticosteroids
NCT03133104 ·Status: COMPLETED
-
The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
NCT04963465 ·Status: UNKNOWN
-
Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane
NCT02104791 ·Status: UNKNOWN
-
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
NCT04705935 ·Status: COMPLETED
-
Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes
NCT05207800 ·Status: UNKNOWN
-
The Placental Secretome as a Therapeutic Tool to Prevent Inflammation-induced Preterm Birth
NCT06891508 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Antiphospholipid Antibodies and Fetal Growth Restriction
NCT01538134 ·Status: UNKNOWN
-
The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
NCT01279369 ·Status: TERMINATED
-
Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
NCT02702297 ·Status: COMPLETED
-
The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes
NCT04100252 ·Status: COMPLETED
-
Antiphospholipid Antibodies and Early Severe Preeclampsia.
NCT01538121 ·Status: UNKNOWN
-
Early Detection of Chorioamnionitis in Preterm Premature Rupture of Membranes
NCT02901795 ·Status: COMPLETED
-
Preterm Premature Rupture of Membranes (PPROM): Bed Rest Versus Activity Trial
NCT01544387 ·Status: COMPLETED ·Phase: NA
-
Can Non-invasive Sampling Determine the Inflammatory Status of the Intra-uterine Environment?
NCT01090583 ·Status: COMPLETED
-
PROM by AmnioQuick Duo+ in Egyptian Women
NCT03435965 ·Status: UNKNOWN
-
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
NCT03715530 ·Status: TERMINATED ·Phase: NA
-
Preterm Premature Rupture of Membranes, Outpatient Management vs Inpatient Management
NCT02548013 ·Status: UNKNOWN ·Phase: NA
-
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377 ·Status: RECRUITING ·Phase: NA
-
Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM
NCT04532021 ·Status: UNKNOWN
-
Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?
NCT02939742 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Procalcitonin and Threatened Premature Delivery
NCT01977079 ·Status: TERMINATED ·Phase: NA
-
Domiciliary Versus Hospital Management of PPROM
NCT04413019 ·Status: COMPLETED